January 19, 2005Open Access

Intermittent Presumptive Treatment for Malaria

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

A better understanding of the pharmacodynamics of intermittent presumptive treatment, says White, will guide more rational policymaking A better understanding of the pharmacodynamics will guide more rational policymaking

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Nicholas J. White (Wed,) studied this question.

synapsesocial.com/papers/6a1d498a43708a372d5e02f5 https://doi.org/https://doi.org/10.1371/journal.pmed.0020003

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Indian Medical Department1941 · 2 citations
2Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study2004 · 94 citations
3The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses1997 · 156 citations
4Importance and prevention of malaria in pregnancy2003 · 152 citations
5Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in <i>Plasmodium falciparum</i>‐endemic sub‐Saharan Africa2003 · 169 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo